Caines, KarenLush, Louisiana2019-09-252019-09-252012-01-112004-092940286213http://hdl.handle.net/20.500.12424/182595"The fragmentation of initiatives, funding and conditionalities is the critical issue which needs to be addressed by all involved in HIV/AIDS treatment and care. This research found that the picture from country level was extremely confused and that the impact of the multiplicity of programmes spread throughout the health system. Lack of integration is related to the novelty of HIV/AIDS treatment programmes in general, the political profile they have received, the high market value of the products involved, and the role that multinational pharmaceutical companies have played. It is reflected in lack of clarity particularly around drug procurement, requisition and distribution processes, and monitoring and evaluation systems. At national and international levels, flexible and responsive systems are needed to rationalise fragmented ARV procurement, based on clear evidence on costs and benefits of different supply sources as well as feasible mechanisms for estimating demand. At national level, coordinated and integrated monitoring and evaluation systems are needed which incorporate the requirements of national drug management systems, international funding agencies and multinational pharmaceutical companies."(pg 6)Pages: 57engWith permission of the license/copyright holderhealth ethicsmedicinePolitical ethicsBioethicsDevelopment ethicsMedical ethicsHealth ethicsBook